John moore mo cell line
John Moore Quotes (2 quotes)
Patient sues UCLA over patent on cell line.
If you haven't read my interview with the book's author, journalist Rebecca Skloot , please do. This fascinating book details Skloot's search for the source of a laboratory cell line called " HeLa. Woven into the tale of the Lacks family and Skloot's search for their history, though, is the story of the HeLa cells and laboratory cell lines in general. And throughout those sections I was reminded that what is legal is not necessarily what is moral or what is fair. And this is an area that we as a society are still trying to figure out.
In September, John Moore, a leukemia patient who has been treated successfully at the University of California, Los Angeles UCLA , filed suit against the University of California on the grounds that two UCLA researchers took unfair advantage of him by using his cells as the basis of research that has led to a patent of undetermined financial value Science, 28 September, p. The case of John Moore versus The Regents of the University of California was the subject of a hearing in federal court in Los Angeles on 29 October when the two sides squared off in a procedural argument over whether the case belongs in state or federal court, or, as UC attorneys argued, in no court at all. The outcome of that hearing--a ruling that the dispute should be heard in California state court--has now set the stage for a case that may turn out to focus on the behavior and motives of the researchers who cared for Moore but somehow left him feeling cheated, even though they saved his life. Attorneys for Moore, a Seattle seafood salesman, see the case as a potentially precedent-setting suit that will spell out previously undefined "rights' that a patient has or ought to have in any commercial products derived from research on his bodily cells or tissues. On the basis of research on cells from Moore's spleen, which was removed in as part of his successful therapy for hairy cell leukemia a rare form of cancer , UCLA scientists David Golde and Shirley Quan developed a productive cell line that they called Mo for Moore and on which they filed a patent in
T-lymphocyte variant of hairy-cell leukemia. Erythroid-potentiating activity: characterization and target cells. Production of erythroid-potentiating activity by a human T-lymphoblast cell line. Growth of human malignant lymphoid cell lines in serum-free medium. In Vitro Unique T-lymphocyte line and products derived therefrom. Patent number US, Mar
This Jello Simulation Uses Only ~88 Lines of Code
SHOWING the wisdom of Solomon, the California Supreme Court last week ruled that, while patients do not have property rights over tissue removed from their bodies during medical treatment, they do have a right to decide how that material will be used in the future. The landmark decision in Moore versus The Regents of the University of California has wide-ranging implications for medical scientists and biotechnology companies worldwide who use human tissue for basic research or the development of commercial products. In a complex page judgment, the panel of judges clearly stated that patients must be protected from unwitting participation in medical research. But if they give their consent to research, they cannot subsequently demand money from medical researchers, claiming that their tissues led to profitable products. Moore was suffering from hairy-cell leukaemia. As a consequence of the disease, his spleen had grown from grams to nearly 6 kilograms.
All human beings like to think they are unique, but John Moore can prove the point: His cells have been legally patented. They have co-opted this part of me. Seeking a second opinion, the father of two flew to Los Angeles, where he was examined by a respected expert in the field—Dr. Golde confirmed the diagnosis and recommended a splenectomy. Moore agreed to submit to the surgery, and in October another UCLA physician removed the grossly enlarged organ. Golde requested and received a piece of the diseased spleen for further analysis.
Osagie K. Polio ravaged much of the United States during the 20th century, leaving thousands sick, paralyzed, and dead. Those who were not afflicted with the virus were constantly haunted by the terror that their loved ones—particularly children, who were most vulnerable—would awaken one morning unable to walk and destined to a life of leg braces and iron lungs. That is until , when Jonas Salk created a vaccine. There were more than 45, total cases of polio in the United States in each of the two years before the vaccine became broadly available.